Cash is not king when it comes to this stock market, Jim Cramer told his Mad Money viewers Monday. In fact, holding the most amount of cash is being held against them.

That was Cramer's analysis after it was reported that a full one-third of all corporate cash is held by just five companies. The stocks of those five companies are not being rewarded for their success and frugality, he said. Rather, they are down an average of 3% for the year.

Apple (AAPL - Get Report) , a stock Cramer owns for his charitable trust, Action Alerts PLUS, has the largest cash hoard, $233 billion, and has a stock that's down 8% for the year. Despite trading at a scant 11 times earnings, Cramer said, Apple is still being viewed as just another device maker with limited growth potential.

Next is Microsoft (MSFT - Get Report) , with $105 billion in cash. Cramer said this company is transitioning from PCs to the cloud but hit a wall this quarter that must be surmounted before the stock can rally from its 9.8% decline.

Third and fourth on the list are two more Action Alerts PLUS names, Alphabet (GOOGL - Get Report) and Cisco Systems (CSCO - Get Report) , with $75 billion and $63 billion in cash, respectively. Cramer said Alphabet needs to do something bold, but he remains a huge fan of buying Cisco aggressively right here given its 3.7% yield.

Finally, there's Oracle (ORCL - Get Report) with $50 billion in cash. Despite trading up 7% for the year at 14 times earnings, Cramer said he'd stay away given the mounting competition in the cloud space from Microsoft and others.

Kamich's Picks

When technician, colleague and market bear Bruce Kamich issued a report that included five bullish stocks, Cramer said he immediately took notice. Kamich might really be onto something.

Cramer said he, too, is bullish on Flowserve (FLS - Get Report) , a specialty valve maker that's downsizing plants and staff while improving its bookings, as well as FMC Technologies (FMC - Get Report) , our nation's eighth-largest crop protection company that also happens to be tripling its lithium production to serve the electric car market.

Franklin Resources (BEN - Get Report) is also on Kamich's list and Cramer said this company's emerging market portfolio could be turning for the better, making this stock a buy.

Fourth on Kamich's list is oil company Helmerich & Payne (HP - Get Report) , which while seeing an upturn in its chart is not a buy, according to Cramer. He said of the company's 347 oil rigs, a full 263 of them are currently idle. Cramer said to take a pass and buy some Schlumberger (SLB - Get Report) instead.

Finally, there is NRG Energy (NRG - Get Report) , the utility that attempted to become an alternative power company at the worst possible time. After the company's CEO resigned in February it's been all uphill for NRG, which is now well off its lows thanks to new management.

So of Kamich's five picks, Cramer said he likes four of them but cannot bless the declining fundamentals at Helmerich & Payne.

Focus on Medical Device Makers

The biotech and pharmaceutical stocks have been taking fire for months thanks to an active political cycle and allegations of price gouging, Cramer told viewers. But with 15% of the S&P 500 made up of healthcare, fund managers have to invest somewhere, and that somewhere has been with the medical device makers.

All seemed lost for medical devices when the Affordable Care Act levied a 2% tax in 2013. Innovation and IPOs in the sector came to an abrupt halt, Cramer explained, until the tax was suspended last year in 2015.

Innovation has returned to medical devices, thanks to new technologies and a rash of takeovers and mergers, fueled by an aging demographic that needs everything this group sells.

Cramer noted C.R. Bard (BCR) issued strong earnings and full-year guidance when it reported, yet still trades at just 19.5 times earnings. He is also a fan of Boston Scientific (BSX - Get Report) , even with shares up 11% after the company reported stellar earnings.

Cramer's favorite in the group remains Edwards Lifesciences (EW - Get Report) , with shares up 27% so far year to date. But he also gave the nod to both Zimmer Holdings (ZBH - Get Report) and Stryker (SYK - Get Report) , which trade at just 13.6 and 17 times earnings, respectively.

Cramer's 'Homework'

In his "Homework" segment, Cramer followed up on a few stocks that stumped him during earlier shows. He said Hannon Armstrong (HASI - Get Report) , a specialty finance company focusing on sustainable energy and with a 6% yield, is worth speculating on if the Federal Reserve holds off on raising interest rates.

Next, Cramer said student loan financier, SLM Corp (SLM - Get Report) , is down 40% from its highs but remains in the political cross-hairs. So, too, does Mednax Health (MD - Get Report) , which trades at just 14 times earnings.

Cramer took a pass on Ship Finance International (SFL - Get Report) , saying he prefers Nordic American Tanker (NAT - Get Report) in this group.

Finally, Cramer was bearish on La Jolla Pharmaceuticals (LJPC - Get Report) , saying that while the stock is very cheap, it has no catalysts for growth.

In his "No Huddle Offense" segment, Cramer said ever since the chatter of a June interest hike emerged, the international stocks have been getting hammered. That may be a signal to buy.

Cramer said McDonald's (MCD - Get Report) and Pepsico (PEP - Get Report) , an Action Alerts PLUS holding, are buys thanks to the Fed-induced weakness. He is also bullish on 3M (MMM - Get Report) , which fell from $170 to $164 in recent days, along with Kimberly-Clark (KMB - Get Report) and Estee Lauder (EL - Get Report) .